HomeCompareTLCC vs MRK

TLCC vs MRK: Dividend Comparison 2026

TLCC yields 500000.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TLCC wins by $4.663521010693878e+33M in total portfolio value
10 years
TLCC
TLCC
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full TLCC calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — TLCC vs MRK

📍 TLCC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTLCCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TLCC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TLCC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TLCC
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, TLCC beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TLCC + MRK for your $10,000?

TLCC: 50%MRK: 50%
100% MRK50/50100% TLCC
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TLCC
No analyst data
Altman Z
-90.7
Piotroski
2/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TLCC buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTLCCMRK
Forward yield500000.00%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.663521010693878e+33M$57.7K
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$10,113.78
Total dividends collected$4.6634009849658873e+33M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TLCC vs MRK ($10,000, DRIP)

YearTLCC PortfolioTLCC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,213$373.04+$50.00MTLCC
2$233,748,371,262$233,694,859,813.08$12,667$512.06+$233748.36MTLCC
3$1,021,074,511,412,696$1,020,824,400,655,446.10$14,439$708.14+$1021074511.40MTLCC
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$16,640$988.16+$4168597328794.94MTLCC
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$19,432$1,394.07+$15905475114600664.00MTLCC
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$23,057$1,992.90+$56718938532531060736.00MTLCC
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$27,889$2,894.79+$1.8903180743562385e+23MTLCC
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$34,518$4,286.29+$5.8879981047651824e+26MTLCC
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$43,912$6,494.35+$1.7140642681147225e+30MTLCC
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$57,714$10,113.78+$4.663521010693878e+33MTLCC

TLCC vs MRK: Complete Analysis 2026

TLCCStock

Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements and other natural products in the United States and internationally. The company offers vitamins, minerals, resveratrol, collagen, keratin, specialty supplements, and sports nutrition products under the Twinlab brand; healthy aging and beauty products under the Reserveage Nutrition and ResVitale brands; diet and energy products under the Metabolife; and a line of herbal teas under the Alvita brand. It also acts as contract manufacturer for private label customers. The company sells its products in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, stick packs, sprays, and powders primarily through health and natural food stores, supermarkets, mass market retailers, specialty stores retailers, online retailers, and websites. Twinlab Consolidated Holdings, Inc. was founded in 2013 and is based in Boca Raton, Florida.

Full TLCC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TLCC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TLCC vs SCHDTLCC vs JEPITLCC vs OTLCC vs KOTLCC vs MAINTLCC vs JNJTLCC vs ABBVTLCC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.